$MXCT
Maxcyte, Inc.
Nasdaq · Healthcare · Services-Commercial Physical & Biological Research · Rockville, MD
MXCT chart
What traders are saying about $MXCT
Latest postsMaxcyte, Inc. news
- MaxCyte Reports $27.1M Revenue and Lower Net Loss for Nine Months Ending September 2026
Kalkine Media ·
- MaxCyte (MXCT) Q3 2026 Earnings Call Transcript
fool.com ·
- MaxCyte Inc (MXCT) (Q3 2026) Earnings Call Highlights: Revenue Surges 49% as Accron Acquisition ...
Yahoo Finance ·
- Rockville's MaxCyte Agrees to Buy Florida's Akron Bio for $151.8 Million, Doubles Revenue Bet
Hoodline ·
- MaxCyte Q3 2026 Earnings Call Transcript
Benzinga ·
- $20M in deferred payments is part of MaxCyte (MXCT)'s agreement to acquire Akron Bio.
Stock Titan ·
- Rockville's MaxCyte buying Akron BioProducts in largest-ever acquisition
The Business Journals ·
- MaxCyte, Inc. Raises earnings Guidance for the Full Year 2026
marketscreener.com ·
- MaxCyte agrees to buy Akron Bio from Arcline for $152 million in cash, stock and deferred payments
MLQ.ai ·
- MaxCyte secures $75M credit facility to fund Akron Bio acquisition
Dealroom ·
- MaxCyte Q3 Earnings Call Highlights
marketbeat.com ·
- MaxCyte (MXCT) Shares Drop Over 10% After $151.8M Akron BioProdu
GuruFocus ·
Maxcyte, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $21.0M | $22.2M | $19.5M | $28.7M |
| Net income | -$44.6M | -$41.1M | -$37.9M | -$23.6M |
| Diluted EPS | $-0.42 | $-0.39 | $-0.37 | $-0.23 |
| Total assets (year end) | $202.5M | $239.5M | $268.3M | $286.7M |
| Cash and equivalents (year end) | $20.1M | $27.9M | $46.5M | $11.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Maxcyte, Inc.
- Ticker
- MXCT (Nasdaq)
- Industry
- Services-Commercial Physical & Biological Research
- Headquarters
- Rockville, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1287098
- Former names
- MAXCYTE INC
Frequently asked questions
What exchange is Maxcyte, Inc. listed on?
Maxcyte, Inc. trades on the Nasdaq under the ticker symbol MXCT.
What industry is Maxcyte, Inc. in?
Maxcyte, Inc. is classified by the SEC under "Services-Commercial Physical & Biological Research", part of the Healthcare sector on StockTweeting.
Where is Maxcyte, Inc. headquartered?
Maxcyte, Inc.'s business address on file with the SEC is in Rockville, MD.
When does Maxcyte, Inc.'s fiscal year end?
Maxcyte, Inc.'s fiscal year ends on December 31.
How much revenue did Maxcyte, Inc. report?
Maxcyte, Inc. reported $21.0M in revenue for calendar year 2025, according to its SEC filings.